Register information Patent

DE file number : 60 2013 084 802.5 (Status: pending/in force, Query started: April 24, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2013 084 802.5
96EP file numberEAKZ21 19 9451.2
97EP publication numberEPN4011915
54Designation/titleTIVERFAHREN ZUR BEHANDLUNG ODER VERHINDERUNG VON ASTHMA DURCH VERABREICHUNG EINES IL-4R-ANTAGONISTEN
51IPC main classICM
(ICMV)		 C07K 16/28 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 39/395 (2006.01)
22DE application dateDATAug 20, 2013
96EP application dateEATAug 20, 2013
43Date of first publicationOTJun 15, 2022
Date of publication of grantPETOct 11, 2023
71/73Applicant/ownerINHRegeneron Pharmaceuticals, Inc., Tarrytown, NY, US; Sanofi Biotechnology, Gentilly, FR
72InventorINARDELEANU, Marius, Tarrytown, NY 10591-6707, US; GANDHI, Namita, Tarrytown, NY 10591-6707, US; GRAHAM, Neil, Tarrytown, NY 10591-6707, US; KIRKESSELI, Stephane C., Bridgewater, NJ 08807, US; KUNDU, Sudeep, Bridgewater, NJ 08807, US; RADIN, Allen, Tarrytown, NY 10591-6707, US; ROCKLIN, Ross E., Bridgewater, NJ 08807, US; WEINSTEIN, Steven P., Tarrytown, NY 10591-6707, US; DAVIDSON HAMILTON, Jennifer, Tarrytown, NY 10591-6707, US; MING, Jeffrey, Bridgewater, NJ 08807, US
Address for service RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB
33
31
32
Foreign priorityPRC
PRNA
PRDA
FR
1356994
Jul 16, 2013
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201361783796 P
Mar 14, 2013
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201261691625 P
Aug 21, 2012
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201361758097 P
Jan 29, 2013
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201361761279 P
Feb 6, 2013
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201361805797 P
Mar 27, 2013
Due dateFT
FG		Aug 31, 2025
Annual fee for the 13th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000004011915A1
Searchable text: EP000004011915A1
Original document: EP000004011915B1
Searchable text: EP000004011915B1
43Date of first publicationEVTJun 15, 2022
Date of the first transfer into DPMAregisterEREGTJun 15, 2022
Date of the (most recent) update in DPMAregisterREGTNov 14, 2024
(Show all update days)(Hide all update days)
  • Nov 14, 2024
    • St.36: changed (technical change)
  • Aug 15, 2024
    • St.36: changed (technical change)
  • Aug 1, 2024
    • St.36: changed (technical change)
  • Jul 25, 2024
    • St.36: changed (technical change)
  • Jul 18, 2024
    • St.36: changed (technical change)
  • Jul 4, 2024; Jun 13, 2024; May 9, 2024; May 2, 2024; Jan 11, 2024; Nov 23, 2023; Oct 19, 2023; Oct 10, 2023; Oct 7, 2023; Sep 21, 2023; Sep 14, 2023
    • Historical data not available for this/these date(s)
  • Jun 15, 2022
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Jun 15, 2022  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Jul 28, 2022 Jul 28, 2022 Details anzeigen
3 New applicant/owner details New applicant/owner details Oct 9, 2023  Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Oct 11, 2023  Details anzeigen
5 Opposition procedure Opposition to patent filed Oct 11, 2023 Nov 23, 2023 Details anzeigen
6 Publications Publication by DPMA of mention regarding EP patent grant Oct 26, 2023 Oct 26, 2023 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTJun 15, 2022
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTJul 28, 2022
Issue numberHN30
YearPJ2022
Publication dateVTJul 28, 2022
Type of publicationPARTBibliographic data
View procedures New applicant/owner details (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTOct 9, 2023
71/73Previous applicant/ownerINHFRegeneron Pharmaceuticals, Inc., Tarrytown, NY, US, Sanofi Biotechnology, Paris, FR
Date of update of the procedureREGTOct 10, 2023
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTOct 11, 2023
Date of update of the procedureREGTSep 21, 2023
View procedures Opposition procedure (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTOpposition procedure
Legal/procedural statusVSTOpposition to patent filed
Date of legal/procedural statusVSTTOct 11, 2023
Issue numberHN47
YearPJ2023
Publication dateVTNov 23, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTNov 23, 2023
View procedures Publications (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTOct 26, 2023
Issue numberHN43
YearPJ2023
Publication dateVTOct 26, 2023
Type of publicationPARTBibliographic data
PartHTPart 5
Date of update of the procedureREGTOct 7, 2023